Emerging investigational agents may shift the current standard of care for patients with the rare sarcoma known as gastrointestinal stromal tumors.
Dr. Vinayak Venkataraman
Advertisement
He currently serves as the director of Sarcoma Pathways and is a physician at Dana-Farber Cancer Institute, in Boston, Massachusetts, where is also an instructor in medicine and an affiliated faculty at the McGraw/Patterson Center for Population Sciences, Harvard Medical School.
Articles by Dr. Vinayak Venkataraman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Breast Cancer Survivor and Nurse Shares Her Story
2
FDA Fast Tracks JSKN003 in Ovarian Cancer
3
Keeping Her Hair Helped Her Feel Normal During Breast Cancer Treatment
4
Experts Break Down Key Insights During Breast Cancer Awareness Month
5
